In TCGA datasets, low‐grade glioma (LGG), colon adenocarcinoma (COAD), prostate adenocarcinoma (PRAD) and stomach adenocarcinoma (STAD) all demonstrated that elevated ABCB5 levels were significantly associated with poor overall survival (Figure S5). Here, ABCB5 is linked to central nervous system cancer.